Clinical Trials Logo

Stage IV Pleural Mesothelioma clinical trials

View clinical trials related to Stage IV Pleural Mesothelioma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02568449 Completed - Clinical trials for Recurrent Pleural Malignant Mesothelioma

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

Start date: March 15, 2016
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well nintedanib works in treating patients with malignant pleural mesothelioma that has come back. Nintedanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.